Diverse Biotech

Diverse Biotech is focused on developing innovative cancer therapies. Their research centers on creating novel molecules by combining existing drugs with cannabinoids through their conjugate synthesis platform. This approach aims to improve efficacy, delivery, and safety. Their pipeline includes promising candidates for cancer, antibiotics, ADCs, platinum agents, and antiprotozoals. DBT-30180, their lead candidate, is being developed for Glioblastoma treatment.

Jobs: